Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics Limited has announced that its 2025 Annual General Meeting will take place on Friday, 31 October 2025. The company has set a deadline for director candidate nominations, not recommended by the Board, for Thursday, 11 September 2025. This meeting is a significant event for stakeholders as it could influence the company’s strategic direction and governance.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand. The company employs some of Australasia’s top radiologists and diagnostic imaging specialists, operating under a unique medical leadership model that emphasizes quality patient care, service, and access.
Average Trading Volume: 1,315,746
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.08B
Find detailed analytics on IDX stock on TipRanks’ Stock Analysis page.